Atkinson C, Penfold C M, Ness A R, Longman R J, Thomas S J, Hollingworth W, Kandiyali R, Leary S D, Lewis S J
Schools of Oral and Dental Sciences, University of Bristol, Bristol, UK.
National Institute for Health Research Biomedical Research Unit in Nutrition, Diet and Lifestyle, University Hospitals Bristol Education Centre, Bristol, UK.
Br J Surg. 2016 Jul;103(8):962-70. doi: 10.1002/bjs.10194. Epub 2016 May 5.
Chewing gum may stimulate gastrointestinal motility, with beneficial effects on postoperative ileus suggested in small studies. The primary aim of this trial was to determine whether chewing gum reduces length of hospital stay (LOS) after colorectal resection. Secondary aims included examining bowel habit symptoms, complications and healthcare costs.
This clinical trial allocated patients randomly to standard postoperative care with or without chewing gum (sugar-free gum for at least 10 min, four times per day on days 1-5) in five UK hospitals. The primary outcome was LOS. Cox regression was used to calculate hazard ratios for LOS.
Data from 402 of 412 patients, of whom 199 (49·5 per cent) were allocated to chewing gum, were available for analysis. Some 40 per cent of patients in both groups had laparoscopic surgery, and all study sites used enhanced recovery programmes. Median (i.q.r.) LOS was 7 (5-11) days in both groups (P = 0·962); the hazard ratio for use of gum was 0·94 (95 per cent c.i. 0·77 to 1·15; P = 0·557). Participants allocated to gum had worse quality of life, measured using the EuroQoL 5D-3L, than controls at 6 and 12 weeks after operation (but not on day 4). They also had more complications graded III or above according to the Dindo-Demartines-Clavien classification (16 versus 6 in the group that received standard care) and deaths (11 versus 0), but none was classed as related to gum. No other differences were observed.
Chewing gum did not alter the return of bowel function or LOS after colorectal resection.
ISRCTN55784442 (http://www.controlled-trials.com).
口香糖可能会刺激胃肠蠕动,小型研究提示其对术后肠梗阻有有益作用。本试验的主要目的是确定口香糖是否能缩短结直肠切除术后的住院时间(LOS)。次要目的包括检查肠道习惯症状、并发症及医疗费用。
在英国五家医院,本临床试验将患者随机分配至接受或不接受口香糖的标准术后护理组(无糖口香糖,每天4次,每次至少10分钟,术后第1 - 5天使用)。主要结局为住院时间。采用Cox回归计算住院时间的风险比。
412例患者中有402例的数据可用于分析,其中199例(49.5%)被分配至口香糖组。两组约40%的患者接受了腹腔镜手术,所有研究地点均采用了加速康复方案。两组的中位(四分位间距)住院时间均为7(5 - 11)天(P = 0.962);使用口香糖的风险比为0.94(95%置信区间0.77至1.15;P = 0.557)。在术后6周和12周时,使用口香糖组患者采用欧洲五维健康量表(EuroQoL 5D - 3L)测量的生活质量比对照组差(但术后第4天无差异)。根据Dindo - Demartines - Clavien分类,他们的III级及以上并发症也更多(接受标准护理组为6例,口香糖组为16例),死亡病例也更多(分别为0例和11例),但均未归类为与口香糖相关。未观察到其他差异。
口香糖并未改变结直肠切除术后肠道功能恢复或住院时间。
ISRCTN5578